Get the Latest Investment Ideas Delivered Straight to Your Inbox. Subscribe


Expert Says Cleantech Stock's Chart Look Better Than Ever
Contributed Opinion

View Important Disclosures for this Article
Share on Stocktwits


Technical Analyst Clive Maund shares an update on BioLargo Inc. (BLGO:OTCQB) to explain how it currently looks even better.

It turns out that, having gone parabolic early this year in a move that was called, BioLargo Inc. (BLGO:OTCQB) wanted to correct deeper and longer than we had expected in the last update posted in April.

However, it now looks better than ever as it has arrived back at its rising 200-day moving average in a fully corrected state, as we can see on its latest 8-month chart shown below, and a range of factors strongly suggest that it will now embark on another upleg. Amongst the bullish factors to observe here is the increase in upside volume in recent weeks, with the Accumulation line showing remarkable strength and advancing to new highs, indicating that the stock has continued to be accumulated even as it has corrected back in a downtrend from its February peak.

With the price believed to be at the second low of a small Double Bottom at support just above the rising 200-day moving average, this looks like an excellent point to buy the stock or add to positions, and this interpretation is bolstered by the fact that that a tranche of warrants exists that have an exercise price of about US$0.25 on average and clearly, holders of these warrants will have no motivation to exercise them with the price down at this level, so this should help to put a floor under the stock.

Lastly, things are continuing to go very well for the various divisions of the company's businesses, and you can review them in the original article on the company posted early in February.

BioLargo Inc. (BLGO:OTCQB) closed at US$0.26 on July 1, 2024

Want to be the first to know about interesting Alternative - Cleantech investment ideas? Sign up to receive the FREE Streetwise Reports' newsletter. Subscribe

Important Disclosures:

  1. BioLargo Inc. is a billboard sponsor of Streetwise Reports and pays SWR a monthly sponsorship fee between US$4,000 and US$5,000. 
  2. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of BioLargo Inc.
  3. Clive Maund: I determined which companies would be included in this article based on my research and understanding of the sector.
  4. Statements and opinions expressed are the opinions of the author and not of Streetwise Reports, Street Smart, or their officers. The author is wholly responsible for the accuracy of the statements. Streetwise Reports was not paid by the author to publish or syndicate this article. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Any disclosures from the author can be found  below. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy. 
  5.  This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company. 

For additional disclosures, please click here. Disclosures

The above represents the opinion and analysis of Mr. Maund, based on data available to him, at the time of writing. Mr. Maund's opinions are his own, and are not a recommendation or an offer to buy or sell securities. As trading and investing in any financial markets may involve serious risk of loss, Mr. Maund recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction, and do your own due diligence and research when making any kind of a transaction with financial ramifications. Although a qualified and experienced stock market analyst, Clive Maund is not a Registered Securities Advisor. Therefore Mr. Maund's opinions on the market and stocks cannot be construed as a recommendation or solicitation to buy and sell securities.

Want to read more about Alternative - Cleantech investment ideas?
Get Our Streetwise Reports' Resources Report Newsletter Free and be the first to know!

A valid email address is required to subscribe